Skip to content
10-Q

Quarterly Report

BIOCLINICA INC

0001104659-12-035890

← back to feed
Filed
May 10, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2012 · Apr 30, 2012 15.64M sh
Shares Diluted Q1 2012 · Mar 31, 2012 16.51M sh
Shares Diluted Q1 2012 · Mar 31, 2011 16.42M sh
Capex Q1 2012 · Mar 31, 2012 $259K
Capex Q1 2012 · Mar 31, 2011 $303K
Operating Cash Flow Q1 2012 · Mar 31, 2012 $1.35M
Operating Cash Flow Q1 2012 · Mar 31, 2011 $1.17M
Cash And Equivalents Q1 2012 · Mar 31, 2012 $12.65M
Cash And Equivalents Q1 2012 · Dec 31, 2011 $12.58M
Cash And Equivalents Q1 2012 · Mar 31, 2011 $10.2M
Cash And Equivalents Q1 2012 · Dec 31, 2010 $10.44M
Stockholders Equity Q1 2012 · Mar 31, 2012 $59.22M
Stockholders Equity Q1 2012 · Dec 31, 2011 $58.06M
Current Liabilities Q1 2012 · Mar 31, 2012 $24.01M
Current Liabilities Q1 2012 · Dec 31, 2011 $24.75M
Total Liabilities Q1 2012 · Mar 31, 2012 $32.14M
Total Liabilities Q1 2012 · Dec 31, 2011 $32.36M
Current Assets Q1 2012 · Mar 31, 2012 $36.48M
Current Assets Q1 2012 · Dec 31, 2011 $36.31M
Total Assets Q1 2012 · Mar 31, 2012 $91.36M
Total Assets Q1 2012 · Dec 31, 2011 $90.42M
Eps Diluted Q1 2012 · Mar 31, 2012 $0.06
Eps Diluted Q1 2012 · Mar 31, 2011 $0.02
Eps Basic Q1 2012 · Mar 31, 2012 $0.06
Eps Basic Q1 2012 · Mar 31, 2011 $0.02
Sga Expense Q1 2012 · Mar 31, 2012 $2.6M
Sga Expense Q1 2012 · Mar 31, 2011 $2.22M
Net Income Q1 2012 · Mar 31, 2012 $994K
Net Income Q1 2012 · Mar 31, 2011 $351K
Operating Income Q1 2012 · Mar 31, 2012 $1.58M
Operating Income Q1 2012 · Mar 31, 2011 $567K
Revenue Q1 2012 · Mar 31, 2012 $22.69M
Revenue Q1 2012 · Mar 31, 2011 $19.67M